dr. litton discusses the potential advantage of using biosimilars in oncology
Published 4 years ago • 59 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
1:48
dr. markman on the concept of biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
5:59
dr ali mcbride discusses the role of biosimilars in oncology
-
0:49
dr. robson discusses differences between biosimilars and biologics in oncology
-
3:33
biosimilars: manufacturing and inherent variation
-
3:00
biosimilars: complex copycat drugs
-
7:21
biologic drugs and biosimilars
-
0:55
dr. weise discusses the value of biosimilars in oncology
-
0:58
dr. hurvitz on the clinical use of biosimilars in oncology
-
1:30
dr. mcbride on the potential impact of bevacizumab biosimilars in oncology
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
1:16
dr. weise discusses the future of biosimilars in oncology
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
7:22
an overview of biosimilarity
-
1:17
dr. lyman on educating physicians about biosimilars in oncology
-
5:58
the availability of multiple biosimilars for 1 biologic
-
0:53
dr. puhalla on the value of biosimilars in oncology
-
0:45
dr. preeshagul on education for biosimilars in oncology
-
0:32
the potential of biosimilars in cancer treatment
-
1:42
advantages of using biosimilars
-
1:02
dr jeremy schafer discusses the importance of immunogenicity of biosimilars